Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Kyntra Bio (KYNB) over the last 11 years, with Q3 2025 value amounting to 0.33%.

  • Kyntra Bio's Return on Capital Employed rose 23800.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year increase of 23800.0%. This contributed to the annual value of 0.81% for FY2024, which is 2700.0% up from last year.
  • Per Kyntra Bio's latest filing, its Return on Capital Employed stood at 0.33% for Q3 2025, which was up 23800.0% from 5.2% recorded in Q2 2025.
  • Kyntra Bio's Return on Capital Employed's 5-year high stood at 0.28% during Q1 2021, with a 5-year trough of 5.2% in Q2 2025.
  • Over the past 5 years, Kyntra Bio's median Return on Capital Employed value was 0.97% (recorded in 2023), while the average stood at 1.18%.
  • The largest annual percentage gain for Kyntra Bio's Return on Capital Employed in the last 5 years was 23800bps (2025), contrasted with its biggest fall of -37900bps (2025).
  • Kyntra Bio's Return on Capital Employed (Quarter) stood at 0.49% in 2021, then plummeted by -82bps to 0.9% in 2022, then tumbled by -61bps to 1.44% in 2023, then increased by 2bps to 1.42% in 2024, then skyrocketed by 77bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 5.2% for Q2 2025, and 1.0% during Q1 2025.